Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

FDA Approves Klor-Con Potassium Chloride Powder For Oral Solution

By Upsher-Smith Laboratories, LLC | November 29, 2017

Upsher-Smith Laboratories, LLC. has launched Klor-Con Powder (potassium chloride) for oral solution, 20 mEq. The company received approval of an abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for this product, which will be marketed and distributed by Upsher-Smith.

Sandoz, Inc. will continue as the licensed marketer and distributor in the U.S. for the balance of the Klor-Con line of potassium products. 

The potassium chloride powder market had U.S. sales of approximately $98 million for the 12 months ending September, 2017, according to IMS Health.

“The past six months have been particularly exciting for Upsher-Smith as we have transitioned from a privately owned company to an integral part of the Sawai Group, a globally driven, publicly traded Japanese company,” said Rusty Field, president and CEO of Upsher-Smith.” 

Product Information

The NDC numbers for Klor-Con Powder (potassium chloride) for oral solution, 20 mEq are 0245-0360-30 for cartons of 30 packets and 0245-0360-01 for cartons of 100 packets. 

Klor-Con is a registered trademark of Upsher-Smith Laboratories, LLC.

(Source: Upsher-Smith Laboratories, LLC)

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE